Representative Experience

• Represented buyers and sellers in various physician practice acquisitions and dispositions. For example, represented MD Health in its acquisition of the assets of a physician practice in California. Some underlying issues included transferring custody of the Seller’s medical records and the transition of the Seller physician to a new ACO. This was a fast-paced deal that we closed within a few weeks of the opening of diligence, and ended with a successful outcome for both our client (Buyer), and Seller.
• Assisted behavioral health company in launching an opioid use disorder treatment service line. The project included reviewing state law on substance use disorder licensing, advising on prescribing Suboxone (buprenorphine) under state and federal law, and reviewing a provider toolkit of legal and regulatory considerations for an opioid use disorder treatment program.
• Represented a substance use disorder treatment program in expanding its operations into new states, including corporate re-structuring, reviewing state corporate practice of medicine exceptions for licensed substance use disorder treatment entities, preparing the operational documents, and providing guidance on state and federal issues associated with expanding the group into new states.
• Represented 2^nd Chance Treatment Program in its acquisition of behavioral health practices in Texas, North Carolina, and Colorado. This transaction required a close review of corporate ownership requirements, state provider and facility licensing requirements, and midlevel supervision and scope of practice issues.
• Advised various provider groups on the ability to utilize unlicensed coaches and the distinction between licensed activity and wellness coaching in behavioral health offerings and nutritional coaching offerings.
• Reviewed state scope of practice requirements for advanced practice registered nurses in all 50-states, including state supervision requirements, prescriptive authority, and independent practice requirements.
• Represented Magellan Health Inc. in growing their behavioral health presence through key acquisitions, including the majority interest in Bayless Integrated Healthcare, a leading integrated behavioral and primary care provider in Arizona, and a minority equity investment into Kaden Health, Inc., the New York-based medication-assisted treatment (vMAT) company.